Spectral AI Awarded $31.7 Million of BARDA Funding to Accelerate Development of the DeepView® System
Spectral AI, Inc. (Nasdaq: MDAI) ('Spectral AI” or the 'Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care ...
It didn't take Mark Thomas long. "Yeah, there it is, I'm pretty sure, " he said as he scanned the twisted metal. "My Jeep." Thomas was ...
Hypertrophic scarring affects a large proportion of patients following burns, trauma, or surgery and arises from prolonged fibroblast hyperactivity and excessive extracellular matrix accumulation.
Biomaterials are specifically engineered to support tissue, nerve and muscle regeneration across the body, yet physicians and ...
In a 40-year career that brought him two Pulitzers, he reported from trouble spots around the world, eloquently conveying the ...
MediWound’s latest earnings call painted a mixed but generally constructive picture for investors, with significant operational advances offset by weak near‑term financials. Management highlighted ...
DALLAS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Serious injuries related to this honey-based product have been reported and could lead to a breach in the sterile barrier resulting in possible patient infection. The Food and Drug Administration (FDA ...
Serious injuries have been reported with the use of these products. The Food and Drug Administration (FDA) has issued a safety alert regarding the potential for serious injury with the use of ...
Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration headquarters in Silver Spring, Md., on Nov. 10, 2020. Integra LifeSciences has recalled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results